-+ 0.00%
-+ 0.00%
-+ 0.00%

CORCEPT THERAPEUTICS INC - DAZALS STUDY MET SECONDARY ENDPOINT OF IMPROVED OVERALL SURVIVAL

Reuters·06/05/2025 10:00:00

Please log in to view news